FDA, Politics

President Trump asks Francis Collins to stay on at the NIH, sparking bipartisan applause

The Mark O. Hatfield Clinical Research Center at the National Institutes of Health Clinical Center. NIH File Photo


Francis Collins

President Donald Trump may want to slash the budget at the NIH, but he also wants Francis S. Collins to stay on as its director.

Collins, a deeply respected scientist who helped lead the charge in mapping the human genome, was initially asked to stay on at least temporarily after Trump took office. But now the administration wants to make that official.

Trump won’t find much opposition to that decision. Collins has also built a considerable amount of support for the NIH budget in Congress, which he’ll need to fight off an attempt by the Trump administration to slash $5.8 billion in spending next year.

Lawmakers, though, didn’t just reject an attempt to cut the NIH’s budget for 2017. They added $2 billion more. And after 8 years at the top, Collins enjoys support from both sides of the aisle, which was highlighted on Twitter last night.

The bulk of the NIH’s budget goes to support researchers whose work forms the foundation that supports clinical stage drug development. Their 20,000 staffers also include a large number of top investigators. It’s been said that if the Trump administration does take the ax to the NIH budget, the primary victims will be all the new researchers looking for their first grants.

With Collins staying on, the likelihood of that happening dropped considerably.


The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 29,000+ biopharma pros who read Endpoints News by email every day.

Free Subscription

RAPS Convergence 2018

Head of DMPK, Director
Magenta Therapeutics Cambridge, MA
Research Scientist - Disease Biology & Cellular Pharmacology
Recursion Pharmaceuticals Salt Lake City
Sr/Medical Director, Medical Affairs
A Rare Disease Biotech New Brunswick, NJ
VP, Pharmacovigilance
Aeglea BioTherapeutics Austin, TX
Process Scientist/Lead
Tmunity Therapeutics Philadelphia, PA

Visit Endpoints Careers ->